The association between AMPD2 (Adenosine Monophosphate Deaminase 2) and Hereditary Spastic Paraplegia is reported, with clinical genetic testing available.
Sources1
Clinical variants2
Symptoms3
Compounds0
Trials0
Publications0
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.